Bel20 (BEL20.BXS)

Close: 3 743.25 (-27.84), Jan 22, 2021
Weak Positive

Medium risk

Automatic technical analysis. Medium term, Jan 22, 2021

Investors have paid higher prices over time to buy Bel20 and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index has support at points 3560 and resistance at points 4200. The RSI curve shows a rising trend, which supports the positive trend. The index is overall assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive (Score: 40)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.14%0.00-0.74%
5 days0.003.94%0.00+0.74%
22 days0.0011.14%0.00+4.85%
66 days0.0025.14%0.00+14.82%

More analyses of Bel20

chart Bel20 (BEL20) Candlesticks 22 Days
Candlesticks
chart Bel20 (BEL20) Short term
Short term: Positive
chart Bel20 (BEL20) Medium term
Medium term: Weak Positive
chart Bel20 (BEL20) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK